News

EBR Systems, Inc., developer of the world’s only left ventricular endocardial pacing (LVEP) system for heart failure, today announced real-world findings from 100 patients across 31 US centers showing a mean acute reduction in QRS duration of...

Stereotaxis Press Release ST. LOUIS, Oct. 22, 2026 -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that Pauls Stradiņš Clinical University...

Medtronic Press Release  GALWAY, Ireland, Oct. 22, 2026 -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced positive real-world registry results for the Affera™ Mapping and Ablation System with the...

Johnson & Johnson Press Release IRVINE, Calif. -- Johnson & Johnson (NYSE: JNJ) today announced new data from the late-breaking VARIPURE and Omny-IRE studies presented at the Asia Pacific Heart Rhythm Society (APHRS) 2026 Annual...

Kardium Press Release VANCOUVER, British Columbia -- Kardium today announced the first site activation and first patient enrollment in the Globe Registry: Globe® Pulsed Field System Registry for Treating Patients with Symptomatic Atrial...

Vektor Medical Press Release SAN DIEGO -- Vektor Medical, a medical technology company advancing the treatment of cardiac arrhythmias through its non-invasive, AI-based arrhythmia analysis technology, vMap®, today announced the completion...

EBR Systems Press Release SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only left ventricular endocardial pacing (LVEP) system for heart failure, announces the appointment of Robert C. Canby, MD, as Chief...

GALWAY, Ireland – October 19 – Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Vitalis™ portfolio of cardiac devices – ReSyncra CSP™, Restoria CSP™, Refina CSP™, Effectra™, and Confirma™...

ACC Press Release WASHINGTON (Oct 15, 2026) - Exercise should be prescribed as a foundational component of cardiovascular disease (CVD) prevention and treatment, according to a new American College of Cardiology Scientific Statement...

Targeted placement of the left ventricular lead did not improve outcomes in patients with heart failure undergoing cardiac resynchronization therapy, according to results presented at ESC Congress 2026.